Dosimetric comparison between Volumetric Modulated Arc Therapy (VMAT) vs Intensity Modulated Radiation Therapy (IMRT) for radiotherapy of mid esophageal carcinoma

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 4, 2014, Pages 871-877

  Kataria, Tejinder ^a   Govardhan, H B ^a   Gupta, Deepak ^a   Mohanraj, U ^a   Bisht, Shyam ^a   Sambasivaselli, R ^a   Goyal, S ^a   Abhishek, A ^a   Srivatsava, A ^a   Pushpan, L ^a   Kumar, V ^a   Vikraman, S ^a  

^a Medanta The Medicity ^*  (India)

Author keywords

Intensity modulate dradiation therapy; mid esophageal carcinoma; volumetric modulated Arc therapy

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGUS CARCINOMA; HEART; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG; MALE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; SPINAL CORD; TREATMENT PLANNING; VOLUMETRIC MODULATED ARC THERAPY; CARCINOMA; CHEMORADIOTHERAPY; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; ESOPHAGEAL NEOPLASMS; METASTASIS; MIDDLE AGED; PROCEDURES; RADIATION RESPONSE; RADIOMETRY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; LUNG; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84921371236     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.138217     Document Type: Article

References (32)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on day/month/year [Last accessed on 2012].
2. Takiar R, Nadayil D, Nandakumar A. Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev 2010;11:1045-9.
3. Bradley JD, Muti S. Carcinoma of the esophagus. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S, editors. Technical Basis of Radiation Therapy: Practical Clinical Applications. 4 th ed. Berlin: Springer; 2008. p. 511-24.
4. Fenkell L, Kaminsky I, Breen S, Huang S, Van Prooijen M, Ringash J. Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol 2008;89:287-91.
5. Rochet N, Kieser M, Sterzing F, Krause S, Lindel K, Harms W, et al. Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III-the OVAR-IMRT-02 Study. BMC Cancer 2011;11:41.
6. Dirix P, Vanstraelen B, Jorissen M, Vander Poorten V, Nuyts S. Intensity-modulated radiotherapy for sinonasal cancer: Improved outcome compared to conventional radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:998-1004.
7. Orlandi E, Palazzi M, Pignoli E, Fallai C, Giostra A, Olmi P. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review. Crit Rev Oncol Hematol 2010;73:111-25.
8. Staffurth J. Radiotherapy Development Board. A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 2010;22:643-57.
9. Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: An exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Int J Radiat Oncol Biol Phys 2012;82:235-41.
10. Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation: An alternative to tomotherapy. Phys Med Biol 1995;40:1435-49.
11. Van Benthuysen L, Hales L, Podgorsak MB. Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer. Med Dosim 2011;36:404-9.
12. Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008;89:180-91.
13. Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, et al. Volumetri0063 modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009;93:226-33.
14. Mayo CS, Ding L, Addesa A, Kadish S, Fitzgerald TJ, Moser R. Initial experience with volumetric IMRT (Rapid Arc) for intracranial stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2010;78:1457-66.
15. A Phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer who are treated without surgery. Available from: http://www.rtog.org/members/protocols/0436/0436.pdf [Last accessed on 2011].
16. Iori M, Cattaneo GM, Cagni E, Fiorini C, Borasi G, Riccardo C, et al. Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours. Radiother Oncol 2008;88:34-45.
17. Whitelaw GL, Blasiak-Wal I, Cooke K, Usher C, Macdougall ND, Plowman PN. A dosimetric comparison between two intensity-modulated radiotherapy techniques: Tomotherapy vs dynamic linear accelerator. Br J Radiol 2008;81:333-40.
18. McIntosh A, Read PW, Khandelwal SR, Arthur DW, Turner AB, Ruchala KJ, et al. Evaluation of coplanar partial left breast irradiation using tomotherapy-based topotherapy. Int J Radiat Oncol Biol Phys 2008;71:603-10.
19. Sheng K, Molloy JA, Larner JM, Read PW. A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol 2007;82:174-8.
20. Joseph KJ, Syme A, Small C, Warkentin H, Quon H, Ghosh S, et al. A treatment planning study comparing helical tomotherapy with intensity-modulated radiotherapy for the treatment of anal cancer. Radiother Oncol 2010;94:60-6.
21. Feuvret L, Noel G, Mazeron JJ, Bey P. Conformity index: A review. Int J Radiat Oncol Biol Phys 2006;64:333-42.
22. Yang GY, McClosky SA, Khushalani NI. Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers. Gastrointest Cancer Res 2009;3:S6-S10.
23. Hazard L, Yang G, McAleer MF, Hayman J, Willett C. Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers. J Natl Compr Canc Netw 2008;6:870-8.
24. Hallock A, Bauman G, Chen J, Yartsev S. Simultaneous in-field boost for brain metastases: In regard to Lagerwaard et al. Int J Radiat Oncol Biol Phys 2009;75:253-259.
25. Int J Radiat Oncol Biol Phys 2010;78:964-5.
26. Guzel Z, Bedford JL, Childs PJ, Nahum AE, Webb S, Oldham M, et al. A comparison of conventional and conformal radiotherapy of the oesophagus: Work in progress. Br J Radiol 1998;71:1076-82.
27. Chen YJ, Liu A, Han C, Tsai PT, Schultheiss TE, Pezner RD, et al. Helical tomotherapy for radiotherapy in esophageal cancer: A preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim 2007;32:166-71.
28. Martin S, Chen JZ, Rashid Dar A, Yartsev S. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT and Arc technique for esophageal carcinoma. Radiother Oncol 2011;101:431-7.
29. Yin L, Wu H, Gong J, Geng JH, Jiang F, Shi AH, et al. Volumetric-modulated arc therapy vs c-IMRT in esophageal cancer: A treatment planning comparison. World J Gastroenterol 2012;18:5266-75.
30. Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 2008;70:707-14.
31. Hawkins MA, Bedford JL, Warrington AP, Tait DM. Volumetric modulated arc therapy planning for distal oesophageal malignancies. Br J Radiol 2012;85:44-52.
32. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB Jr, Ajani JA, et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 2003;57;1317-22.